Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).
MyChesCo on MSN21h
Globus Medical to Acquire Nevro Corp. in Strategic $250 Million DealGlobus Medical (NYSE: GMED) has announced a definitive agreement to acquire all shares of Nevro Corp. (NYSE: NVRO) in an ...
20hon MSN
Find insight on AstraZeneca, Eli Lilly, Siemens Healthineers and more in the latest Market Talks covering Health Care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback